NCT00075140
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
- Locations
-
- The University of Iowa College of Nursing Iowa City, Iowa, United States
Clinical trial condition
Neurodegenerative Diseases
Explore clinical trials studying Neurodegenerative Diseases. Study availability and eligibility vary by location and protocol.
8,970 public trials
1,744 recruiting studies
Neurodegenerative Diseases trial results
Completed
Effects of Estrogen on Memory in Post-Menopausal Women and Patients With Alzheimer's Disease
NCT00006399
- Conditions
- Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
- Clinical Neuroscience Research Unit, University of Vermont Burlington, Vermont, United States
NCT00558337
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
- Locations
-
- Fundacion Alfredo Thomson Buenos Aires, Argentina
- Hospital Posadas Buenos Aires, Argentina
- Hospital Ramos Mejía Buenos Aires, Argentina
- Hospital Sirio Libanés Buenos Aires, Argentina
NCT00442780
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
- Locations
-
- Research Site Ashkelon, Israel
- Research Site Petah Tikva, Israel
- Research Site Ramat Gan, Israel
- Research Site Tel Aviv, Israel
NCT00505167
- Conditions
- Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +7 more
- Locations
-
- Hospital de Barbastro Barbastro, Huesca, Spain
- Cenro de especialidades San José. Hospital Miguel Servet Zaragoza, Spain
- Hospital Royo Villanova Zaragoza, Spain
NCT00551772
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
- Locations
-
- GSK Investigational Site Evansville, Indiana, United States
Completed
Study of the Effect of SR57667B on 18F-Dopa PET Imaging in Patients With Parkinson's Disease
NCT00220272
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
- Sanofi-Aventis Administrative Office Laval, Canada
- Sanofi-Aventis Administrative Office Helsinki, Finland
- Sanofi-Aventis Administrative Office Paris, France
- Sanofi-Aventis Administrative Office Gouda, Netherlands
NCT00285077
- Conditions
- Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
- Sanofi-Aventis Administrative Office Laval, Canada
- Sanofi-Aventis Administrative Office Horslholm, Denmark
- Sanofi-Aventis Administrative Office Helsinki, Finland
- Sanofi-Aventis Administrative Office Paris, France
Completed
Study of the Effect of SR57667B on the Progression of Symptoms in Patients With Parkinson's Disease
NCT00228150
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
- Sanofi-Aventis Administrative Office Vienna, Austria
- Sanofi-Aventis Administrative Office Laval, Canada
- Sanofi-Aventis Administrative Office Hørsholm, Denmark
- Sanofi-Aventis Administrative Office Paris, France
NCT00380302
- Conditions
- Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
- Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States
- Sanofi-Aventis Administrative Office Paris, France
- Sanofi-Aventis Administrative Office Milan, Italy
- Sanofi-Aventis Administrative Office Gouda, Netherlands